Capital Flow Monitor · Sponsors · CIK 1945154
SonoThera, Inc.
201 HASKINS WAY, 5TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080 · 510-414-2997
Biotechnology · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$125.5M
Sold
$125.5M
% sold
100.0%
Investors
22
Min investment
$0
Exemption
506(c)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | D ·current | 506(c) | $125.5M | $125.5M | 100.0% | 22 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Kenneth Greenberg — Executive Officer / Director, South San Francisco, CA
-
Michael Davidson — Executive Officer / Director, South San Francisco, CA
1 other raise
- VoiceIt Technologies, Inc dba EnQuanta $10.1M of —
-
Steven Gillis — Director, South San Francisco, CA
2 other raises
- ARCH Venture Fund XIV, L.P. $0 of $3.0B · 0.0%
- Pheast Therapeutics, Inc. $24.6M of $40.0M · 61.5%
-
Brian Halak — Director, South San Francisco, CA
1 other raise
- ThirdLaw Molecular, Inc. $5.5M of $5.5M · 100.0%
-
Rajul Jain — Director, South San Francisco, CA
2 other raises
- Vida Ventures IV, L.P. $0 of $500.0M · 0.0%
- Quanta Therapeutics, Inc. $76.2M of $89.1M · 85.5%
-
Rakhshita Dhar — Director, South San Francisco, CA
2 other raises
- NextPoint Therapeutics, Inc. $33.7M of $48.7M · 69.2%
- RECODE THERAPEUTICS, INC. $29.4M of $29.4M · 100.0%
- Steven Feinstein — Executive Officer, South San Francisco, CA
- Carolyne Zimmerman — Executive Officer, South San Francisco, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.